---
title: "SCN1A"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Analysis of Gene SCN1A "
tags: ['SCN1A', 'SodiumChannel', 'MissenseMutation', 'DravetSyndrome', 'Anticonvulsant', 'DrugResponse', 'NeurologicalDisorders', 'GeneticInformationAnalysis']
---

# Analysis of Gene SCN1A 

## Gene Information 
- Function: The SCN1A gene encodes a sodium channel alpha subunit, which is involved in the generation and propagation of action potentials in neurons.
- External IDs: 
    - HGNC: 10587
    - NCBI Entrez: 6323
    - Ensembl: ENSG00000196712
    - OMIM: 182389
    - UniProtKB/Swiss-Prot: Q9UQD0

## Genomic Location and Aliases 
- Chromosome: 2q24.3
- Alias: Nav1.1

## Mutation Information 
- AA mutation list: 
    - p.Arg1648His
    - p.Thr226Met
    - p.Met1322Val
    - p.Asp1859Val
- Mutation type: Missense
- dbSNP ID: rs121917773, rs121917772, rs121917769, rs121917771 

## Somatic SNVs/InDels 
- dbSNP ID: rs193922916
- Mutation type: Missense

## Related Diseases 
- Dravet syndrome
- Generalized epilepsy with febrile seizures plus (GEFS+)

## Treatment and Prognosis 
- Treatment: Anticonvulsant medications
- Prognosis: Prognosis varies depending on the severity of the condition and the effectiveness of treatment.

## Drug Response 
- Sodium channel blockers have been found to be effective in treating Dravet syndrome patients with SCN1A mutations.

## Related Papers 
- Subject: SCN1A-related disorders
- Author name: MÃ¸ller RS, et al.
- DOI links: 10.1016/B978-0-444-59565-2.00019-8

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**